← Back to Clinical Trials
Recruiting NCT07450456

NCT07450456 Effect of Virtual Reality on the Need of Premedication Before Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07450456
Status Recruiting
Phase
Sponsor Ente Ospedaliero Cantonale, Bellinzona
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-11-11
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Virtual Reality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-11-11 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will assess, on patients requesting a pharmacological premedication in the preoperative period, if virtual reality reality could reduce the request of pharmacological premedication while maintaining a good level of comfort for the patient. The aim of this study is to understand if virtual reality could reduce the need for pharmacological premedication and their associated secondary effects.

Eligibility Criteria

Inclusion Criteria: * All patients undergoing elective surgery * Minimal age of 18-year-old * Able to give informed consent for the study * Requesting pharmacological premedication in the pre-operative period. Exclusion Criteria: * Lacking capacity or ability to complete the consent form or to respond to the required obligations linked to the study protocol * Contraindications to pharmacological premedication * Known cognitive dysfunction, previous history of neurological/psychiatric diseases like epilepsy * Non Italian speaking patients * Injuries to the head/face that would prohibit wearing headsets * Infectious skin conditions of the head/face * Contact isolation due to bacteria and viruses * Symptoms of vertigo or motion sickness * Reduced visual or auditory acuity * Pregnancy * Claustrophobia

Contact & Investigator

Central Contact

Hervé Schlotterbeck, Medical Doctor

✉ herve.schlotterbeck@eoc.ch

📞 0041 91 811 51 89

Frequently Asked Questions

Who can join the NCT07450456 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07450456 currently recruiting?

Yes, NCT07450456 is actively recruiting participants. Contact the research team at herve.schlotterbeck@eoc.ch for enrollment information.

Where is the NCT07450456 trial being conducted?

This trial is being conducted at Lugano, Switzerland.

Who is sponsoring the NCT07450456 clinical trial?

NCT07450456 is sponsored by Ente Ospedaliero Cantonale, Bellinzona. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology